Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. - Test2 - elhamkhani - TriplyDB

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

http://www.wikidata.org/entity/Q36843561

about

Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity.Sex Disparity in Cord Blood FoxP3+ CD4 T Regulatory Cells in Infants Exposed to Malaria In Utero.Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.Malaria during Pregnancy.The potential benefit of scaling up malaria prevention to reduce low birth weight in Africa.Dihydroartemisinin-piperaquine holds promise as an option for malaria prevention in pregnancy.Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda.Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial.Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation.Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.Malarial Infection and Curable Sexually Transmitted and Reproductive Tract Infections Among Pregnant Women in a Rural District of Zambia.Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.Treatment regimens for pregnant women with falciparum malaria.Prevention and control of malaria in pregnancy - new threats, new opportunities?Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial.Gilding the Lily? Enhancing Antenatal Malaria Prevention in HIV-Infected Women.Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.The application of physiologically-based pharmacokinetic modelling to assess the impact of antiretroviral-mediated drug-drug interactions on piperaquine antimalarial therapy during pregnancy.Changing antimalarial drug sensitivities in Uganda.Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes.Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial?Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.Management of malaria in pregnancy.A non-pharmaceutical form of Artemisia annua is not effective in preventing Plasmodium falciparum malaria.A randomized trial of the prophylactic activity of DSM265 against pre-erythrocytic Plasmodium falciparum controlled human malaria infection by mosquito bites and direct venous inoculation.A brief review on features of falciparum malaria during pregnancy.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial

P2860

Q28553597-C8C144C0-923C-46F8-B7BD-F2262DE55775 Q30245481-BE22F6E1-28CE-481B-9C0F-E70DCC99DE9C Q33629511-15C2A742-FE5E-4FD6-B033-31C02FA63FFE Q33662226-2F4944A9-4AA4-4A40-8528-01CBE1C16645 Q36185610-A3F332CC-3E3E-4426-882B-74C2506AB0AE Q36284603-B28E82A9-BBFA-4840-938F-1385809F59B2 Q36292794-C786A613-FCD2-48BF-910B-D9D360FC8441 Q37156238-F90BE421-59AD-4B83-8604-8CAEDEB8CB35 Q37211931-2FC13AA2-7A5B-4DA0-89E6-98580A21CC7B Q37280776-2ED1684F-D621-4982-8A4A-FF711CA11B73 Q37287899-EB0A789C-FE3B-4B9A-9B45-39198F24EDFF Q37322188-1C83B048-E9F0-48F1-9439-0990F3B36F02 Q37327771-1C5C3F8A-F383-43D9-A65C-3A532D4EBA83 Q37607325-5DD2DFF7-EC06-4409-A5E4-8097AFE4B893 Q37835430-E238392B-17EB-4554-B7C5-AE48303A97B8 Q38632443-CFB4AD42-C64A-45BE-A814-872D49D79502 Q38850820-2B02C662-ED6F-41CA-8180-C1B77EDB158C Q38851261-72BA6E6A-A4F9-41EF-AF4D-E7B102F5DEC5 Q38851726-A1221BDE-D12D-49A7-BC94-F7EDC0C2DA00 Q38870452-CA0E54AF-63E2-4D36-A2BA-B5DC6FA27A5C Q39038490-6E6F270D-E301-4D47-88B5-559491812A82 Q39327919-C8978A0E-3534-49D3-B46B-03F53367F595 Q39517560-F1A18A34-5E95-4E80-B345-A60D08FFE775 Q40106428-84D917DB-21F4-41E0-8604-C81E009563F8 Q40133890-9CF6AF35-1D32-484F-9FEB-D7154EDFF59D Q41911931-82C0FDF9-F5D9-40F0-A166-59D205F77ACB Q41990717-91975022-C80B-4E01-BC50-6156B2693BE7 Q41992238-B98FB108-F90E-406C-9452-34387BC2F7A6 Q42330176-CF16854C-FB49-4E9E-AA5C-D4A8BF4214AF Q47258627-3429F8A0-21FB-4BBE-87E8-6BCA4CF59517 Q47797899-92F5CE76-1B01-4985-A155-56252BDF0EAC Q47966039-9E04F472-B2A1-4BD4-9CE1-4BDF10AB8049 Q48018719-24C0CF62-4949-43BE-BB92-2BC57DCF598A Q49874138-EC471B32-6495-46C3-B282-C7F2BD468DF0 Q56352635-87815770-7D75-4E54-B6D7-BD481030497C Q56355681-CB983B60-5E8C-4BED-8A76-43D9AC922578 Q56362278-00F85737-8F1B-4F2F-B739-21051B1319EE

P2860

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

http://www.wikidata.org/entity/Q36843561

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

@en

type

label

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

@en

prefLabel

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

@en

P1433

Q36843561-A636B21F-9AB3-4D49-B884-456A308D3FE5

P1476

Q36843561-346281D6-E29E-4BB9-AC2D-8842957F1A9D

P2093

Q36843561-11466D78-A129-45DC-9905-24A2EE2FCB9F

Q36843561-1836C2ED-4CA4-415D-87C8-156FD2DBB48C

Q36843561-2E1C36C7-5A0C-4B03-B17D-5098836DB8B7

Q36843561-38D5E50B-F447-46DE-AA6B-B4FCCC853BF8

Q36843561-3B9B3C6F-4443-412D-96D6-F4E3A2F0859A

Q36843561-3CCBA143-D530-4C64-B56C-DBDDF1176760

Q36843561-41590C49-7FB9-4183-A794-50A97E227B64

Q36843561-51B3D7F3-A31F-4576-AC57-B64937FCDA8B

Q36843561-583A2F69-C7B3-443B-8519-AF41CC7B691A

Q36843561-81D1E310-6ADC-4C3F-B336-37E07A01A7DC

P2860

Q36843561-00FE6F37-FD1C-48ED-8F86-E1178E963EBB

Q36843561-0D7EFF09-FB14-4B74-9156-B102F12216F6

Q36843561-10CE9035-E225-4513-8746-F4AB282FA3CD

Q36843561-1CA22A3A-D991-445E-8C2D-4AB3496F5131

Q36843561-1EBB546B-6529-403E-B714-1AE9F1BA850E

Q36843561-2AF88B66-3D93-4ABF-9A71-758D47B345C7

Q36843561-2F167D1C-E00C-4D73-84B1-FE09995D552C

Q36843561-30CB3CF7-0B21-40A0-9672-0A15C8752DE0

Q36843561-3F71707A-9ED6-408A-AC86-E78F21CCF910

Q36843561-5D002576-52F6-49C0-89D7-E02A279B6D6F

P304

Q36843561-B1BEC919-129C-4172-BD0D-FF8A62478F73

P31

Q36843561-7676A23B-4029-4863-A95F-4E188909E980

P356

Q36843561-9D98A4D6-882E-4A22-8CF4-48BD12B59290

P407

Q36843561-D1DD7607-6A99-42DF-8591-16F05A6EF6A7

P433

Q36843561-875FE2D7-40F3-4589-A9D6-BDE226B8F9DD

P478

Q36843561-0949B10C-B0E3-4717-92FC-8C106F633F2A

P50

Q36843561-2D49CA51-B265-4517-9784-623014950FA2

Q36843561-75013E49-6E9B-4D0E-A739-14C679C3A2C3

Q36843561-84D78747-B069-4B60-9D32-0C85A3D15A0C

Q36843561-D92EFC75-6623-4FA2-8986-101FD60FA09B

Q36843561-F1A2BCEE-CAEA-41D3-9FED-A62F47C62348

P577

Q36843561-204ECE66-6B9E-41AB-B1C6-63D1C26837AC

P698

Q36843561-838050FE-D33E-4A1A-AD03-D15E1BC69DE4

P921

Q36843561-11A9A8EF-C9C8-414A-B0F4-5936C4BFB580

Q36843561-4F0466E0-22EE-4094-9B60-78D2C7A478F0

Q36843561-93F4FFB8-B8DD-46B6-9924-9E33AC99A3D0

P932

Q36843561-6128865E-AF7D-4A8D-A9D3-57003A12E5C7

P356

P1433

The New England Journal of Medicine

P1476

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

@en

P2093

Abel Kakuru

http://www.w3.org/2001/XMLSchema#string

Bishop Opira

http://www.w3.org/2001/XMLSchema#string

Gabrielle Rizzuto

http://www.w3.org/2001/XMLSchema#string

John Ategeka

http://www.w3.org/2001/XMLSchema#string

Margaret E Feeney

http://www.w3.org/2001/XMLSchema#string

Mary K Muhindo

http://www.w3.org/2001/XMLSchema#string

Miriam Nakalembe

http://www.w3.org/2001/XMLSchema#string

Patience Nayebare

http://www.w3.org/2001/XMLSchema#string

Patricia Awori

http://www.w3.org/2001/XMLSchema#string

Paul Natureeba

http://www.w3.org/2001/XMLSchema#string

P2860

High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

Intermittent presumptive treatment for malaria

Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda

Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study

Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.

The burden of malaria in pregnancy in malaria-endemic areas.

The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa.

P304

928-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1509150

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

374

http://www.w3.org/2001/XMLSchema#string

P50

Atis Muehlenbachs

Edwin D Charlebois

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26962728

http://www.w3.org/2001/XMLSchema#string

P921

pregnancy-associated malaria

malaria prevention

P932

4847718

http://www.w3.org/2001/XMLSchema#string